Chile
| Article
PEGylated PLGA Nanoparticles As a Smart Carrier to Increase the Cellular Uptake of a Coumarin-Based Monoamine Oxidase B Inhibitor
dc.creator | Fernandes C. | |
dc.creator | Martins C. | |
dc.creator | Fonseca A. | |
dc.creator | Nunes R. | |
dc.creator | Matos M.J. | |
dc.creator | Silva R. | |
dc.creator | Garrido J. | |
dc.creator | Sarmento B. | |
dc.creator | Remião F. | |
dc.creator | Otero-Espinar F.J. | |
dc.creator | Uriarte E. | |
dc.creator | Borges F. | |
dc.date.accessioned | 2020-09-02T22:17:26Z | |
dc.date.accessioned | 2022-11-08T20:22:37Z | |
dc.date.available | 2020-09-02T22:17:26Z | |
dc.date.available | 2022-11-08T20:22:37Z | |
dc.date.created | 2020-09-02T22:17:26Z | |
dc.date.issued | 2018 | |
dc.identifier | 10, 46, 39557-39569 | |
dc.identifier | 19448244 | |
dc.identifier | https://hdl.handle.net/20.500.12728/4435 | |
dc.identifier.uri | https://repositorioslatinoamericanos.uchile.cl/handle/2250/5144494 | |
dc.language | en | |
dc.publisher | American Chemical Society | |
dc.subject | cytotoxicity | |
dc.subject | drug release | |
dc.subject | efflux transporters | |
dc.subject | intestinal and brain permeability | |
dc.subject | MAO-B inhibitors | |
dc.subject | P-glycoprotein | |
dc.subject | Parkinson's disease | |
dc.subject | polymeric nanosystems | |
dc.subject | Assays | |
dc.subject | Cell culture | |
dc.subject | Clinical research | |
dc.subject | Controlled drug delivery | |
dc.subject | Cytotoxicity | |
dc.subject | Drug products | |
dc.subject | Endothelial cells | |
dc.subject | Glycoproteins | |
dc.subject | Nanoparticles | |
dc.subject | Blood-brain barrier | |
dc.subject | Drug release | |
dc.subject | Efflux transporter | |
dc.subject | Monoamine oxidase B | |
dc.subject | Nanoprecipitation method | |
dc.subject | P-glycoprotein | |
dc.subject | Parkinson's disease | |
dc.subject | Pharmacokinetic properties | |
dc.subject | Targeted drug delivery | |
dc.subject | amine oxidase (flavin containing) | |
dc.subject | coumarin | |
dc.subject | coumarin derivative | |
dc.subject | drug carrier | |
dc.subject | monoamine oxidase inhibitor | |
dc.subject | nanoparticle | |
dc.subject | surfactant | |
dc.subject | Caco-2 cell line | |
dc.subject | chemistry | |
dc.subject | human | |
dc.subject | IC50 | |
dc.subject | Parkinson disease | |
dc.subject | permeability | |
dc.subject | scanning electron microscopy | |
dc.subject | tumor cell line | |
dc.subject | Caco-2 Cells | |
dc.subject | Cell Line, Tumor | |
dc.subject | Coumarins | |
dc.subject | Drug Carriers | |
dc.subject | Humans | |
dc.subject | Inhibitory Concentration 50 | |
dc.subject | Microscopy, Electron, Scanning | |
dc.subject | Monoamine Oxidase | |
dc.subject | Monoamine Oxidase Inhibitors | |
dc.subject | Nanoparticles | |
dc.subject | Parkinson Disease | |
dc.subject | Permeability | |
dc.subject | Polylactic Acid-Polyglycolic Acid Copolymer | |
dc.subject | Surface-Active Agents | |
dc.title | PEGylated PLGA Nanoparticles As a Smart Carrier to Increase the Cellular Uptake of a Coumarin-Based Monoamine Oxidase B Inhibitor | |
dc.type | Article |